Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-17T05:16:27.620Z Has data issue: false hasContentIssue false

Methicillin-Resistant Staphylococcus aureus: How Reliable is Laboratory Reporting?

Published online by Cambridge University Press:  02 January 2015

David W. Fleming
Affiliation:
Respiratory and Special Pathogens Branch, Center for Infectious Disease, Atlanta, GeorgiaOffice of the Director, Centers for Disease Control, Atlanta, Georgia
Steven D. Helgerson
Affiliation:
Respiratory and Special Pathogens Branch, Center for Infectious Disease, Atlanta, GeorgiaOffice of the Director, Centers for Disease Control, Atlanta, Georgia
Barbara L. Mallery
Affiliation:
Respiratory and Special Pathogens Branch, Center for Infectious Disease, Atlanta, GeorgiaOffice of the Director, Centers for Disease Control, Atlanta, Georgia
Laurence R. Foster*
Affiliation:
Respiratory and Special Pathogens Branch, Center for Infectious Disease, Atlanta, GeorgiaOffice of the Director, Centers for Disease Control, Atlanta, Georgia
Mary C. White
Affiliation:
Respiratory and Special Pathogens Branch, Center for Infectious Disease, Atlanta, GeorgiaOffice of the Director, Centers for Disease Control, Atlanta, Georgia
*
Oregon Health Division, 1400 S.W. Fifth Avenue, Portland, OR 97201

Abstract

Microbiology laboratories in Oregon were surveyed in 1981 to determine how often methicillin-resistant Staphylococcus aureus (MRSA) was being reported to physicians in the state. Results of this survey were surprising in three respects. First, the mean percent of S. aureus isolates reported by laboratories as methicillin-resistant was 8.3%. Second, a significant inverse correlation was found between the percent of reported MRSA and laboratory size (p=0.0001). Finally, laboratories which retested initially resistant isolates reported significantly less MRSA (mean 3.3%, median 1%) than those laboratories which accepted initial results (mean 20%, median 12%) (p=0.0001). Independent testing by the Centers for Disease Control of isolates reported to be MRSA confirmed that some misideiitification was occurring. Participating laboratories were notified of our initial findings and their potentially serious clinical ramifications. Laboratories were resurveyed in 1982, and a significant decrease in the reported MRSA to a mean percentage of 3.4% was observed (p=<0.002). It is unlikely that this situation is unique to Oregon, and similar misreporting of MRSA to physicians in other areas of the country may be compromising the safe and effective treatment of S. aureus infections.

Information

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable